Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Michael

Showing results (1201-1210 of 1,306) with videos related to

Pageof 131
Sort By:
Journal of the American College of Cardiology|September 26, 2018
5-Year Outcomes of Self-Expanding Transcatheter Versus Surgical Aortic Valve Replacement in High-Risk PatientsThomas G Gleason, Michael J Reardon, Jeffrey J Popma, et al.
Journal of Neurology|July 23, 2020
The neuro-otology of Susac syndromeTodd A Hardy, Rachael L Taylor, Jessica Qiu, et al.
ACS Infectious Diseases|December 21, 2020
The SARS-CoV-2 Cytopathic Effect Is Blocked by Lysosome Alkalizing Small MoleculesKirill Gorshkov, Catherine Z Chen, Robert Bostwick, et al.
JAMA|July 27, 2021
Effect of a Hospital and Postdischarge Quality Improvement Intervention on Clinical Outcomes and Quality of Care for Patients With Heart Failure With Reduced Ejection Fraction: The CONNECT-HF Randomized Clinical TrialAdam D DeVore, Bradi B Granger, Gregg C Fonarow, et al.
JAMA|November 7, 2018
Effect of Inorganic Nitrite vs Placebo on Exercise Capacity Among Patients With Heart Failure With Preserved Ejection Fraction: The INDIE-HFpEF Randomized Clinical TrialBarry A Borlaug, Kevin J Anstrom, Gregory D Lewis, et al.
Lancet (London, England)|November 13, 2012
Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trialJohn R Teerlink, Gad Cotter, Beth A Davison, et al.
BMJ Open|February 25, 2022
Bedtime versus morning use of antihypertensives for cardiovascular risk reduction (BedMed): protocol for a prospective, randomised, open-label, blinded end-point pragmatic trialScott R Garrison, Michael R Kolber, G Michael Allan, et al.
The Journal of Clinical Investigation|February 3, 2022
Lysosomal exocytosis of HSP70 stimulates monocytic BMP6 expression in Sjögren's syndromeYing-Qian Mo, Hiroyuki Nakamura, Tsutomu Tanaka, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 30, 2020
Multiscale computation delivers organophosphorus reactivity and stereoselectivity to immunoglobulin scavengersYuliana A Mokrushina, Andrey V Golovin, Ivan V Smirnov, et al.
JACC. Heart Failure|December 1, 2022
Functional and Symptomatic Clinical Trial Endpoints: The HFC-ARC Scientific Expert PanelMitchell A Psotka, William T Abraham, Mona Fiuzat, et al.
Pageof 131

Showing results (1201-1210 of 1,306) with videos related to

Sort By:
Pageof 131
Journal of the American College of Cardiology|September 26, 2018
5-Year Outcomes of Self-Expanding Transcatheter Versus Surgical Aortic Valve Replacement in High-Risk PatientsThomas G Gleason, Michael J Reardon, Jeffrey J Popma, et al.
Journal of Neurology|July 23, 2020
The neuro-otology of Susac syndromeTodd A Hardy, Rachael L Taylor, Jessica Qiu, et al.
ACS Infectious Diseases|December 21, 2020
The SARS-CoV-2 Cytopathic Effect Is Blocked by Lysosome Alkalizing Small MoleculesKirill Gorshkov, Catherine Z Chen, Robert Bostwick, et al.
JAMA|July 27, 2021
Effect of a Hospital and Postdischarge Quality Improvement Intervention on Clinical Outcomes and Quality of Care for Patients With Heart Failure With Reduced Ejection Fraction: The CONNECT-HF Randomized Clinical TrialAdam D DeVore, Bradi B Granger, Gregg C Fonarow, et al.
JAMA|November 7, 2018
Effect of Inorganic Nitrite vs Placebo on Exercise Capacity Among Patients With Heart Failure With Preserved Ejection Fraction: The INDIE-HFpEF Randomized Clinical TrialBarry A Borlaug, Kevin J Anstrom, Gregory D Lewis, et al.
Lancet (London, England)|November 13, 2012
Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trialJohn R Teerlink, Gad Cotter, Beth A Davison, et al.
BMJ Open|February 25, 2022
Bedtime versus morning use of antihypertensives for cardiovascular risk reduction (BedMed): protocol for a prospective, randomised, open-label, blinded end-point pragmatic trialScott R Garrison, Michael R Kolber, G Michael Allan, et al.
The Journal of Clinical Investigation|February 3, 2022
Lysosomal exocytosis of HSP70 stimulates monocytic BMP6 expression in Sjögren's syndromeYing-Qian Mo, Hiroyuki Nakamura, Tsutomu Tanaka, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 30, 2020
Multiscale computation delivers organophosphorus reactivity and stereoselectivity to immunoglobulin scavengersYuliana A Mokrushina, Andrey V Golovin, Ivan V Smirnov, et al.
JACC. Heart Failure|December 1, 2022
Functional and Symptomatic Clinical Trial Endpoints: The HFC-ARC Scientific Expert PanelMitchell A Psotka, William T Abraham, Mona Fiuzat, et al.
Pageof 131